Genesys Spine announced today the first two patients have been enrolled in the prospective SIros™ Lateral Sacroiliac Fusion Study. Dr. Tyler Ptacek, Rapid City, S. Dak. and Dr. Douglas Beall, Oklahoma City, Okla., were the first physicians in the study to enroll patients. This clinical study will be conducted across four centers in the United States.
To assist with patient reimbursement solutions, Austin-based medical device manufacturer Genesys Spine is partnering with PRIA Healthcare. The partnership focuses on improving patient reimbursement for Genesys Spine’s SIros™ and SIrten™ SI joint fusion systems.
Medical device manufacturer Genesys Spine announced today that its SI Joint Division exceeded 2021 sales targets with 184 percent growth over 2020.
Lateral Sacroiliac Joint Fusion – SIros 3D Printed
Posterior Sacroiliac Joint Fusion – SIrten Allograft
Hybrid – SIros 3D Printed + SIrten Allograft